Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Price to Earnings (2021 - 2023)

Updated

Moderna's (MRNA) Price to Earnings came in at 38.35 for Q2 2023, up 862.6% from 3.98 a year earlier and up 211.1% from the prior quarter.

Analysis

Moderna (MRNA) Price to Earnings (2021 - 2023) Analysis & Trends

For FY2022, Moderna's Price to Earnings stood at 8.27, down 1.4% from FY2021.

  • In prior years, Moderna's Price to Earnings was 8.39 in FY2021.
  • The Q2 2023 figure stands as the highest quarterly Price to Earnings since Q1 2021.
  • On a year-over-year basis, Price to Earnings increased in two of the last six quarters, with growth averaging 126.8%.
  • According to Business Quant data, Price to Earnings for the three prior quarters was 12.33 (Q1 2023), 8.27 (Q4 2022) and 3.89 (Q3 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 38.35
Mar 31, 2023 12.33
Dec 31, 2022 8.27
Sep 30, 2022 3.89
Jun 30, 2022 3.98
Mar 31, 2022 4.71
Dec 31, 2021 8.39
Sep 30, 2021 22.07
Jun 30, 2021 27.09
Mar 31, 2021 87.81
API Access

Moderna Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=MRNA&period=max&api_key=YOUR_API_KEY